9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2018
- PMID: 29222380
- DOI: 10.2337/dc18-S009
9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2018
Abstract
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2017 by the American Diabetes Association.
Similar articles
-
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2019.Diabetes Care. 2019 Jan;42(Suppl 1):S103-S123. doi: 10.2337/dc19-S010. Diabetes Care. 2019. PMID: 30559236 Review.
-
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018.Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27. doi: 10.2337/dc18-S002. Diabetes Care. 2018. PMID: 29222373 Review.
-
3. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2018.Diabetes Care. 2018 Jan;41(Suppl 1):S28-S37. doi: 10.2337/dc18-S003. Diabetes Care. 2018. PMID: 29222374 Review.
-
4. Lifestyle Management: Standards of Medical Care in Diabetes-2018.Diabetes Care. 2018 Jan;41(Suppl 1):S38-S50. doi: 10.2337/dc18-S004. Diabetes Care. 2018. PMID: 29222375 Review.
-
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2021.Diabetes Care. 2021 Jan;44(Suppl 1):S125-S150. doi: 10.2337/dc21-S010. Diabetes Care. 2021. PMID: 33298421 Review.
Cited by
-
Investigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of >500 000 patients in the USA.BMJ Open. 2023 Nov 10;13(11):e075840. doi: 10.1136/bmjopen-2023-075840. BMJ Open. 2023. PMID: 37949625 Free PMC article.
-
Association between metformin treatment and coronary artery inflammation based on pericoronary adipose tissue attenuation in type 2 diabetes mellitus patients.J Clin Hypertens (Greenwich). 2024 Apr;26(4):330-337. doi: 10.1111/jch.14777. Epub 2024 Mar 2. J Clin Hypertens (Greenwich). 2024. PMID: 38430483 Free PMC article.
-
Adherence of physicians to evidence-based management guidelines for treating type 2 diabetes and atherosclerotic cardiovascular disease in Ajman, United Arab Emirates.BMC Prim Care. 2022 Apr 7;23(1):70. doi: 10.1186/s12875-022-01672-4. BMC Prim Care. 2022. PMID: 35392814 Free PMC article.
-
Combination of Empagliflozin and Metformin Therapy: A Consideration of its Place in Type 2 Diabetes Therapy.Clin Med Insights Endocrinol Diabetes. 2018 Jul 10;11:1179551418786258. doi: 10.1177/1179551418786258. eCollection 2018. Clin Med Insights Endocrinol Diabetes. 2018. PMID: 30013414 Free PMC article. Review.
-
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Diabetes Care. 2018 Dec;41(12):2669-2701. doi: 10.2337/dci18-0033. Epub 2018 Oct 4. Diabetes Care. 2018. PMID: 30291106 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials